Author:
Cai Xiaoling,Yang Wenjia,Zhou Lingli,Zhang Simin,Han Xueyao,Ji Linong
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference28 articles.
1. J.F. Habener, Insulinotropic glucagon-like peptides, in Diabetes Mellitus: A Fundamental and Clinical Text, 2nd edn., ed. by D. LeRoith, S.I. Taylor, J.M. Olefsky (Lippincott Williams & Wilkins, Philadelphia, 2000)
2. K. Aaboe, T. Krarup, S. Madsbad, J.J. Holst, GLP-1: physiological effects and potential therapeutic applications. Diabetes Obes. Metab. 10, 994–1003 (2008)
3. A.J. Garber, Incretin effects on β-cell function, replication, and mass: the human perspective. Diabetes Care 34(Suppl 2), S258–S263 (2011)
4. F.A. Van de Laar, P.L. Lucassen, R.P. Akkermans, E.H. Van de Lisdonk, G.E. Rutten, C. Van Weel, Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2, CD003639 (2005)
5. A. Karasik, P. Aschner, H. Katzeff, M.J. Davies, P.P. Stein, Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials. Curr. Med. Res. Opin. 24, 489–496 (2008)
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献